246 related articles for article (PubMed ID: 35508185)
1. Epitranscriptomics in fibroblasts and fibrosis.
Ilieva M; Uchida S
Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1110-C1116. PubMed ID: 35508185
[TBL] [Abstract][Full Text] [Related]
2. Epitranscriptomics in liver disease: Basic concepts and therapeutic potential.
Zhao Z; Meng J; Su R; Zhang J; Chen J; Ma X; Xia Q
J Hepatol; 2020 Sep; 73(3):664-679. PubMed ID: 32330603
[TBL] [Abstract][Full Text] [Related]
3. The role of m
Chen XY; Zhang J; Zhu JS
Mol Cancer; 2019 May; 18(1):103. PubMed ID: 31142332
[TBL] [Abstract][Full Text] [Related]
4. Adenosine-to-Inosine RNA Editing in Health and Disease.
Gatsiou A; Vlachogiannis N; Lunella FF; Sachse M; Stellos K
Antioxid Redox Signal; 2018 Sep; 29(9):846-863. PubMed ID: 28762759
[TBL] [Abstract][Full Text] [Related]
5. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
[TBL] [Abstract][Full Text] [Related]
6. A-to-I RNA editing as a tuner of noncoding RNAs in cancer.
Liao Y; Jung SH; Kim T
Cancer Lett; 2020 Dec; 494():88-93. PubMed ID: 32822814
[TBL] [Abstract][Full Text] [Related]
7. Identification of pathology-specific regulators of m
Li N; Zhan X
EPMA J; 2020 Sep; 11(3):485-504. PubMed ID: 32849929
[TBL] [Abstract][Full Text] [Related]
8. N6-methyl-adenosine (m6A) in RNA: an old modification with a novel epigenetic function.
Niu Y; Zhao X; Wu YS; Li MM; Wang XJ; Yang YG
Genomics Proteomics Bioinformatics; 2013 Feb; 11(1):8-17. PubMed ID: 23453015
[TBL] [Abstract][Full Text] [Related]
9. Adenosine-to-inosine RNA editing meets cancer.
Dominissini D; Moshitch-Moshkovitz S; Amariglio N; Rechavi G
Carcinogenesis; 2011 Nov; 32(11):1569-77. PubMed ID: 21715563
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic, progressive and prognostic performance of m
Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y
Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949
[No Abstract] [Full Text] [Related]
11. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
Yuting K; Ding D; Iizasa H
Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
[TBL] [Abstract][Full Text] [Related]
12. Methods for the Detection of Adenosine-to-Inosine Editing Events in Cellular RNA.
Oakes E; Vadlamani P; Hundley HA
Methods Mol Biol; 2017; 1648():103-127. PubMed ID: 28766293
[TBL] [Abstract][Full Text] [Related]
13. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
14. m
Takemoto S; Nakano M; Fukami T; Nakajima M
Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357
[TBL] [Abstract][Full Text] [Related]
15. N (6)-Methyladenosine (m(6)A) Methylation in mRNA with A Dynamic and Reversible Epigenetic Modification.
Wu R; Jiang D; Wang Y; Wang X
Mol Biotechnol; 2016 Jul; 58(7):450-9. PubMed ID: 27179969
[TBL] [Abstract][Full Text] [Related]
16. EndoVIPER-seq for Improved Detection of A-to-I Editing Sites in Cellular RNA.
Knutson SD; Heemstra JM
Curr Protoc Chem Biol; 2020 Jun; 12(2):e82. PubMed ID: 32469473
[TBL] [Abstract][Full Text] [Related]
17. Dynamic and reversible RNA N
Duan HC; Wang Y; Jia G
Wiley Interdiscip Rev RNA; 2019 Jan; 10(1):e1507. PubMed ID: 30252201
[TBL] [Abstract][Full Text] [Related]
18. The Critical Role of RNA m
Lan Q; Liu PY; Haase J; Bell JL; Hüttelmaier S; Liu T
Cancer Res; 2019 Apr; 79(7):1285-1292. PubMed ID: 30894375
[TBL] [Abstract][Full Text] [Related]
19. The Epitranscriptome and Innate Immunity.
O'Connell MA; Mannion NM; Keegan LP
PLoS Genet; 2015 Dec; 11(12):e1005687. PubMed ID: 26658668
[TBL] [Abstract][Full Text] [Related]
20. Adenosine-to-inosine RNA editing.
Zinshteyn B; Nishikura K
Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
